ID: ALA2238395

Max Phase: Preclinical

Molecular Formula: C21H21NO3S

Molecular Weight: 367.47

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1ccc(COc2ccc(NS(=O)(=O)c3ccc(C)cc3)cc2)cc1

Standard InChI:  InChI=1S/C21H21NO3S/c1-16-3-7-18(8-4-16)15-25-20-11-9-19(10-12-20)22-26(23,24)21-13-5-17(2)6-14-21/h3-14,22H,15H2,1-2H3

Standard InChI Key:  HZJUTDSLLJUNAE-UHFFFAOYSA-N

Associated Targets(non-human)

Cholesteryl ester transfer protein 233 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 367.47Molecular Weight (Monoisotopic): 367.1242AlogP: 4.68#Rotatable Bonds: 6
Polar Surface Area: 55.40Molecular Species: NEUTRALHBA: 3HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 8.24CX Basic pKa: CX LogP: 5.05CX LogD: 5.00
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.69Np Likeness Score: -1.28

References

1. Abu Khalaf R, Abu Sheikha G, Al-Shaer M, Albadawi G, Taha M.  (2012)  Design, synthesis, and biological evaluation of sulfonic acid ester and benzenesulfonamide derivatives as potential CETP inhibitors,  21  (11): [10.1007/s00044-011-9917-5]

Source